Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 25INDUSTRY 9NIH 2UNKNOWN 1OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Stomach Neoplasms 3Nasopharyngeal Carcinoma 3Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Nasopharyngeal Neoplasms 1Locally Advanced Malignant Neoplasm 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Epirubicin 4Paclitaxel 3Cyclophosphamide 3Carboplatin 3anlotinib 2Capecitabine 2pirarubicin 1lobaplatin 1eribulin 1Zoledronic Acid 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Triple Negative Breast Neoplasms × Cisplatin × Clear all
NCT01928680 2015-02-23

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

ChineseAMS

Phase 2 Unknown
33 enrolled 5 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡